Back
Alterity Therapeutics Stock Predictions
Sponsored
ATHE
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
ATHE
Alterity Therapeutics
Last Price:
$2.49
Seasonality Move:
-7.11%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.Alterity Therapeutics Stock Forecast
-
Is Alterity Therapeutics Stock Undervalued?The current Alterity Therapeutics [ATHE] share price is $2.45. The Score for ATHE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ATHE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Alterity Therapeutics Stock Go Up Next Year?
Data Unavailable
Alterity Therapeutics Stock Rating
Data Unavailable
Alterity Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Australia
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alteritytherapeutics.com
52-Week Data
52-Week High:
3.19
52-Week Low:
1.00
Prediction Charts
Market Cap:
21.4M
Price in USD:
2.45
Volume:
37.5K
Beta:
0.94
Technical Analysis
SMA50:
1.50
SMA100:
1.41
SMA200:
1.67
52-Wk Change:
-8.24%
Stock Predictions
-
Is Alterity Therapeutics stock public?Yes, Alterity Therapeutics is a publicly traded company.
-
What is the Alterity Therapeutics stock quote today?The Alterity Therapeutics stock price is 2.45 USD today.
-
How to buy Alterity Therapeutics stock online?You can buy Alterity Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-5 | 1.99 | 1.94 | 2.19 | 1.90 |
Dec-6 | 2.07 | 2.15 | 2.19 | 2.00 |
Dec-9 | 2.19 | 2.48 | 2.50 | 2.19 |
Dec-10 | 2.40 | 2.32 | 2.40 | 2.12 |
Dec-11 | 2.21 | 2.27 | 2.33 | 2.19 |
Dec-12 | 2.35 | 2.22 | 2.35 | 2.18 |
Dec-13 | 2.33 | 2.40 | 2.40 | 2.21 |
Dec-16 | 2.40 | 2.31 | 2.45 | 2.25 |
Dec-17 | 2.25 | 2.27 | 2.28 | 2.13 |
Dec-18 | 2.25 | 2.16 | 2.26 | 2.04 |
Dec-19 | 2.10 | 2.10 | 2.15 | 2.05 |
Dec-20 | 2.06 | 2.20 | 2.25 | 2.05 |
Dec-23 | 2.21 | 2.40 | 2.47 | 2.20 |
Dec-24 | 2.40 | 2.45 | 2.60 | 2.40 |
Alterity Therapeutics Earnings
Data Unavailable
Alterity Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.54 per share.
* Alterity Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.